News24
12 Sep 2019, 02:13 GMT+10
Pharmaceutical company Aspen's [JSE:APN] net profit declined 14% as the group disposed of some of its businesses during the period as part of its strategic review to focus on pharmaceuticals.
The pharma group on Wednesday released its financial results for the year ended June 2019.
While revenue increased slightly by 1% to R38.9bn, normalised earnings before interest, taxation, depreciation and amortisation was 4% lower at R10.8bn due to weaker results from the group's manufacturing businesses. Operating profit took a 35% dip to R5.5bn. Higher net financing costs also contributed to an 8% decline in normalized headline earnings to R6.5bn.
Normalised headline earnings per share was 7% lower at R14.14. Net profit was down 14% from R8.3bn reported in the previous year to R7.07bn.
During the period the group announced a strategic review of its European and South African commercial businesses to be more "market-focused", according to the board's statement in the financial report. While the review of the group's European commercial business is ongoing, the South African business review has been completed.
In the closing six months of the year the group completed the disposal of its Nutritionals Business and a portfolio of products which are distributed in Asia Pacific. The disposal translated into cash proceeds of R12.3bn (before tax) and a combined profit on disposal of R5.4bn. The proceeds from disposals have helped reduce net borrowings from R53.5bn, as reported on December 31, 2018 to R39bn by year-end.
Aspen rockets after good news on debt
"While the past year has presented its challenges, we have achieved most of our short-term goals.
"The completion of the disposals of the Nutritionals Business and the non-core product portfolio has allowed us to fully focus on our core pharmaceuticals business," the board said in the financial report.
The board elected not to declare a dividend. "Taking into account our prioritisation of deleveraging the balance sheet, existing debt service commitments during the 2020 financial year and the short-term requirements of the ongoing capital projects, notice is hereby given that the board has decided that it would not be prudent to declare a dividend at this time," the statement read.
"The board will re-evaluate the relevant circumstances regularly with a view to declaring a dividend when it is considered prudent to do so."
Get a daily dose of Israel Herald news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Israel Herald.
More InformationDHARAMSHALA, India: The Dalai Lama turned 90 on July 6, celebrated by thousands of followers in the Himalayan town of Dharamshala,...
ZAGREB, Croatia: A massive concert by popular Croatian singer Marko Perković, known by his stage name Thompson, has drawn widespread...
WASHINGTON, D.C.: Elon Musk's entry into the political arena is drawing pushback from top U.S. officials and investors, as his decision...
CULVER CITY, California: TikTok is preparing to roll out a separate version of its app for U.S. users, as efforts to secure a sale...
WASHINGTON, D.C.: President Donald Trump claimed he was unaware that the term shylock is regarded as antisemitic when he used it in...
PARIS, France: A strike by French air traffic controllers demanding improved working conditions caused significant disruptions during...
OTTAWA, Canada: With Canada Post struggling to maintain operations amid labour unrest, rivals like FedEx and UPS are stepping in to...
NEW YORK, New York - U.S. and global markets showed a mixed performance in Tuesday's trading session, with some indices edging higher...
PARIS, France: French military and intelligence officials have accused China of orchestrating a covert campaign to damage the reputation...
NEW DELHI, India: Birkenstock is stepping up its efforts to protect its iconic sandals in India, as local legal representatives conducted...
HONG KONG: China has fired back at the European Union in an escalating trade dispute by imposing new restrictions on medical device...
NEW YORK, New York - Monday's trading session saw mixed performances across U.S. and global markets, with several major indices posting...